Showing results (171-180 of 409) with videos related to

Sort By:
Pageof 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parametersA Haitel, H G Wiener, U Baethge, et al.
European Urology|January 1, 1981
A study of the effectiveness of inosine in renal transplantationJ M Fitzpatrick, M Marberger, S K Koh, et al.
The Journal of Urology|February 26, 1999
Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasiaB Djavan, C G Roehrborn, S Shariat, et al.
American Journal of Clinical Pathology|February 1, 1997
Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas?A Haitel, H G Wiener, B Migschitz, et al.
European Urology|April 29, 1998
Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimensB Djavan, K Kadesky, B Klopukh, et al.
Urology|September 11, 2001
Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significanceA Haitel, H G Wiener, B Neudert, et al.
European Urology|January 1, 1983
Renal blood flow alterations after temporary ischemia. An experimental model in the rabbitH Pflüger, M Maier, M Wagner, et al.
Neurourology and Urodynamics|May 25, 1999
The International Prostate Symptom score in both sexes: a urodynamics-based comparisonS Madersbacher, A Pycha, C H Klingler, et al.
Cancer|April 8, 1999
Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markersA Haitel, H G Wiener, U Blaschitz, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1991
Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis modelZ W Hruby, R P Lowry, R D Forbes, et al.
Pageof 41